{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T05:57:26Z","timestamp":1769752646757,"version":"3.49.0"},"reference-count":33,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>WHO recommends simplified antibiotics for young infants with sepsis in countries where hospitalisation is not feasible. Amoxicillin provides safe, Gram-positive coverage. This study was done to determine pharmacokinetics, drug disposition and interpopulation variability of oral amoxicillin in this demographic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Young infants with signs of sepsis enrolled in an oral amoxicillin\/intramuscular gentamicin treatment arm of a sepsis trial in Karachi, Pakistan, were studied. Limited pharmacokinetic (PK) sampling was performed at 0, 2\u20133 and 6\u20138\u2009hours following an index dose of oral amoxicillin. Plasma concentrations were determined by high-performance liquid chromatography\/mass spectrometry. Values of \u22652\u2009mg\/L were considered as the effect threshold, given the regional minimal inhibitory concentration (MIC) of resistant <jats:italic>Streptococcus pneumoniae.<\/jats:italic><\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Amoxicillin concentrations were determined in 129 samples from 60 young infants. Six of 44 infants had positive blood cultures with predominant Gram-positive organisms. Forty-four infants contributing blood at \u22652 of 3 specified timepoints were included in the analysis. Mean amoxicillin levels at 2\u20133\u2009hours (11.6\u00b19.5\u2009mg\/L, n=44) and 6\u20138\u2009hours (16.4\u00b19.3\u2009mg\/L, n=20) following the index dose exceeded the MIC for amoxicillin (2.0\u2009mg\/L) against resistant <jats:italic>S. pneumoniae<\/jats:italic> strains. Of 20 infants with three serum levels, 7 showed a classic dose\u2013exposure profile and 13 showed increasing concentrations with time, implying delayed absorption or excretion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Amoxicillin concentrations in sera of young infants following oral administration at 75\u2013100\u2009mg\/kg\/day daily divided doses exceeds the susceptibility breakpoint for &gt;50% of a 12-hour dosing interval.<\/jats:p><jats:p>Oral amoxicillin may hold potential as a safe replacement of parenteral ampicillin in newborn sepsis regimens, including aminoglycosides, where hospitalisation is not feasible.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01027429\">NCT01027429<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2019-317342","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T21:16:47Z","timestamp":1589404607000},"page":"1208-1214","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Serum amoxicillin levels in young infants (0\u201359 days) with sepsis treated with oral amoxicillin"],"prefix":"10.1136","volume":"105","clinical-trial-number":[{"clinical-trial-number":"nct01027429","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8602-5353","authenticated-orcid":false,"given":"Fatima","family":"Mir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin E","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naila","family":"Baig-Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamim","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Abdel-Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita KM","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"2022100606100627000_105.12.1208.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"2022100606100627000_105.12.1208.2","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2010.191"},{"key":"2022100606100627000_105.12.1208.3","unstructured":"World Health Organization . Students\u2019 Handbook for IMNCI Integrated Management of Neonatal and Childhood Illness: Department of Child and Adolescent Health and Development (CAH. World Health Organization, 2003."},{"key":"2022100606100627000_105.12.1208.4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00636-08"},{"key":"2022100606100627000_105.12.1208.5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cpt.748","article-title":"Population pharmacokinetics of amoxicillin in term neonates undergoing moderate hypothermia","volume":"103","author":"Bijleveld","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"2022100606100627000_105.12.1208.6","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.997-1001.2003"},{"key":"2022100606100627000_105.12.1208.7","doi-asserted-by":"publisher","DOI":"10.2165\/0148581-200810060-00006"},{"key":"2022100606100627000_105.12.1208.8","first-page":"679","article-title":"[Comparison of plasma levels of amoxicillin administered by oral and intravenous routes in neonatal bacterial colonization]","volume":"45","author":"Autret","year":"1988","journal-title":"Arch Fr Pediatr"},{"key":"2022100606100627000_105.12.1208.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0307-3"},{"key":"2022100606100627000_105.12.1208.10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.2.431"},{"key":"2022100606100627000_105.12.1208.11","first-page":"476","article-title":"[Pharmacokinetic and clinical investigation of amoxicillin administered intravenously in the newborn ]","volume":"30","author":"Peskine","year":"1982","journal-title":"Pathol Biol"},{"key":"2022100606100627000_105.12.1208.12","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318067de5c"},{"key":"2022100606100627000_105.12.1208.13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/bmc.881","article-title":"Microanalysis of amoxicillin, flucloxacillin, and rifampicin in neonatal plasma","volume":"21","author":"Pullen","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"2022100606100627000_105.12.1208.14","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000198648.39751.11"},{"key":"2022100606100627000_105.12.1208.15","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1093\/jac\/dkz252","article-title":"Oral antibiotics for neonatal infections: a systematic review and meta-analysis","volume":"74","author":"Keij","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2022100606100627000_105.12.1208.16","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S2214-109X(14)70347-X","article-title":"Safety and efficacy of alternative antibiotic regimens compared with 7 day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised, open-label, equivalence trial","volume":"3","author":"Baqui","year":"2015","journal-title":"Lancet Glob Health"},{"key":"2022100606100627000_105.12.1208.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62284-4"},{"key":"2022100606100627000_105.12.1208.18","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S2214-109X(16)30335-7","article-title":"Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial","volume":"5","author":"Mir","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2022100606100627000_105.12.1208.19","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/INF.0b013e31829ff7aa","article-title":"Simplified antibiotic regimens for the management of clinically diagnosed severe infections in newborns and young infants in first-level facilities in Karachi, Pakistan: study design for an outpatient randomized controlled equivalence trial","volume":"32 Suppl 1","author":"Zaidi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"2022100606100627000_105.12.1208.20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.3.353"},{"key":"2022100606100627000_105.12.1208.21","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1990.01870050090013"},{"key":"2022100606100627000_105.12.1208.22","doi-asserted-by":"publisher","DOI":"10.1086\/598975"},{"key":"2022100606100627000_105.12.1208.23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/00034894810903S210","article-title":"Pharmacology of oral antibiotics used for treatment of otitis media and tonsillopharyngitis in infants and children","volume":"90","author":"Ginsburg","year":"1981","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"2022100606100627000_105.12.1208.24","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.11.3029-3036.2001"},{"key":"2022100606100627000_105.12.1208.25","doi-asserted-by":"crossref","DOI":"10.1097\/01.ftd.0000249946.20294.59","article-title":"Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates","volume":"28","author":"van den Anker","year":"2006","journal-title":"Ther Drug Monit"},{"key":"2022100606100627000_105.12.1208.26","unstructured":"Guideline . Managing possible serious bacterial infection in young infants when referral is not feasible. World Health Organization, 2015."},{"key":"2022100606100627000_105.12.1208.27","unstructured":"Guideline . Operationalizing management of sick young infants with possible serious bacterial infection (PSBI) when referral is not feasible in the context of existing maternal, newborn,and child health programmes. World Health Organization, 2017."},{"key":"2022100606100627000_105.12.1208.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra035092"},{"key":"2022100606100627000_105.12.1208.29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1651-2227.1991.tb11752.x","article-title":"Ampicillin-aminoglycoside combinations as initial treatment for neonatal septicaemia or meningitis. A retrospective evaluation of 12 years' experience","volume":"80","author":"Tessin","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"2022100606100627000_105.12.1208.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(03)00030-9"},{"key":"2022100606100627000_105.12.1208.31","doi-asserted-by":"publisher","DOI":"10.1021\/js970068l"},{"key":"2022100606100627000_105.12.1208.32","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1542\/peds.64.5.627","article-title":"Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children","volume":"64","author":"Ginsburg","year":"1979","journal-title":"Pediatrics"},{"key":"2022100606100627000_105.12.1208.33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/j.1552-4604.1978.tb01561.x","article-title":"Evaluation of amoxicillin therapy in ill children","volume":"18","author":"Marks","year":"1978","journal-title":"J Clin Pharmacol"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2019-317342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:12:46Z","timestamp":1665061966000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2019-317342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,11,20]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/archdischild-2019-317342"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2019-317342","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]}}}